| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.072 | 0.1 |